By using Cytokine & Growth factors high-sensitivity array technology our study demonstrates that patients with stable coronary artery disease have significantly lower serum levels of vascular growth factors VGEF and EGF as well as of MCP-1 than healthy volunteers. This evidence concerns the gene EGF and coronary artery disorder.